Adrenal Stress Responses in Critical Illness: Mechanisms, Clinical Implications, and Management

Abstract

The adrenal stress response is pivotal in the adaptation to critical illness, orchestrating hemodynamic stability, metabolic regulation, and immune modulation. Dysregulation of adrenal function, including critical illness-related corticosteroid insufficiency (CIRCI), is increasingly recognized as a contributor to morbidity and mortality in intensive care unit (ICU) populations. This review synthesizes current evidence on the epidemiology, pathophysiology, risk factors, clinical manifestations, diagnostic strategies, and management of adrenal stress responses in critically ill patients. We further discuss guideline-based recommendations and highlight emerging advances with practical clinical implications for intensivists and acute care physicians.

Introduction

Critical illness triggers profound physiological stress, necessitating rapid neuroendocrine adaptation to preserve homeostasis. The hypothalamic-pituitary-adrenal (HPA) axis is central to this response, with adrenal corticosteroids modulating cardiovascular tone, metabolism, and immune responses. Inadequate or excessive adrenal stress responses may exacerbate outcomes in sepsis, trauma, and other life-threatening conditions. Recognizing and managing adrenal dysfunction are thus essential competencies for clinicians in acute care settings. This review provides a comprehensive overview of adrenal stress responses in critical illness, integrating mechanistic insights with clinical management strategies.

Epidemiology / Disease Burden

Adrenal dysfunction is prevalent among critically ill patients, particularly those with sepsis, septic shock, trauma, and major surgery. CIRCI affects up to 25-60% of patients with septic shock, depending on diagnostic criteria and patient cohorts. The burden is magnified by increased morbidity, prolonged ICU stay, higher vasopressor requirements, and elevated mortality rates. Despite advances in supportive care, timely identification and management of adrenal insufficiency remain challenging, underscoring the importance of heightened clinical vigilance and systematic screening in high-risk populations.

Pathophysiology

The adrenal stress response is mediated by activation of the HPA axis, resulting in corticotropin-releasing hormone (CRH) and arginine vasopressin release from the hypothalamus, adrenocorticotropic hormone (ACTH) secretion from the pituitary, and subsequent cortisol synthesis in the adrenal cortex. In critical illness, this axis may be perturbed at multiple levels. Proinflammatory cytokines (e.g., IL-6, TNF-α) can inhibit ACTH release and impair adrenal responsiveness. Sepsis and shock may cause adrenal ischemia, hemorrhage, or direct cytopathic injury. Medication effects (e.g., etomidate, corticosteroids) and underlying comorbidities further influence HPA axis integrity. The net result may be insufficient cortisol production, tissue resistance to glucocorticoids, or, less commonly, hypercortisolemia, each with distinct clinical consequences.

Risk Factors

Major risk factors for adrenal insufficiency in critical illness include severe sepsis or septic shock, major trauma, burns, cardiac arrest, pancreatitis, and liver failure. Additional contributors include a history of chronic corticosteroid therapy, autoimmune adrenalitis, pituitary or adrenal gland disorders, and exposure to medications that suppress cortisol synthesis (e.g., etomidate, azole antifungals). Elderly patients and those with underlying endocrine dysfunction are particularly vulnerable. Recognizing these risk factors facilitates early diagnosis and targeted intervention in at-risk individuals.

Clinical Features

Adrenal dysfunction in critically ill patients is often clinically occult or masked by overlapping features of critical illness. Hallmark signs include refractory hypotension unexplained by hypovolemia or cardiac dysfunction, persistent vasopressor dependence, unexplained hyponatremia, hyperkalemia, hypoglycemia, and altered mental status. Non-specific symptoms such as fatigue, anorexia, and abdominal pain are less common but may be present. CIRCI is typically suspected in patients with septic shock who remain hypotensive despite adequate fluid resuscitation and vasopressor support.

Diagnosis

Diagnosis of adrenal insufficiency in critical illness is complex and controversial. Baseline random serum cortisol levels <10 μg/dL (276 nmol/L) are suggestive, while dynamic testing with ACTH stimulation (250 μg corticotropin) remains the diagnostic gold standard. An increment <9 μg/dL (248 nmol/L) post-stimulation supports CIRCI. However, critical illness alters cortisol-binding proteins and adrenal responsiveness, limiting test sensitivity. Current guidelines advocate for pragmatic clinical diagnosis, emphasizing the context of shock, refractory hypotension, and supportive laboratory findings rather than rigid biochemical cutoffs.

Treatment & Management

Prompt corticosteroid replacement is indicated for suspected adrenal insufficiency in critical illness, particularly in patients with septic shock unresponsive to fluids and vasopressors. Hydrocortisone (200 mg/day, typically divided into boluses or continuous infusion) is favored due to its glucocorticoid and modest mineralocorticoid effects. Fludrocortisone may be added in select cases of primary adrenal insufficiency. Tapering is recommended as hemodynamic stability is restored. Routine steroid use in all critically ill patients is not supported and carries risks of hyperglycemia, secondary infection, and neuromuscular weakness. Individualized therapy, guided by clinical judgment and evolving evidence, is paramount.

Recent Advances / Emerging Therapies

Recent research has refined our understanding of adrenal dysfunction in the critically ill. Advances include recognition of tissue glucocorticoid resistance, assessment of free (rather than total) cortisol, and exploration of selective glucocorticoid receptor modulators. Ongoing trials are evaluating optimal dosing, duration, and delivery methods for corticosteroids in septic shock. Biomarkers such as ACTH, DHEA-S, and 11β-HSD1 activity are under investigation to enhance diagnostic accuracy and prognostication. Adjunctive therapies targeting adrenal perfusion and inflammation-modulating agents represent future directions in the field.

Guideline Recommendations

International guidelines from the Society of Critical Care Medicine (SCCM) and the Surviving Sepsis Campaign recommend corticosteroid therapy in adult septic shock patients who remain hypotensive despite adequate fluid and vasopressor support. Hydrocortisone (200 mg/day) is the agent of choice, with or without fludrocortisone. Steroid therapy should not be initiated solely for ARDS or severe pneumonia without shock. Monitoring for adverse effects, glycemic control, and infection surveillance is emphasized. Guidelines underscore individualized risk-benefit assessment and frequent reassessment of ongoing need for corticosteroid supplementation.

Conclusion

The adrenal stress response plays a critical role in the pathophysiology and outcomes of critical illness. Early recognition and management of adrenal dysfunction, particularly CIRCI, can significantly influence hemodynamic stability and survival in ICU patients. Recent advances highlight the complexity of adrenal physiology and the need for nuanced diagnostic and therapeutic approaches. Adherence to evidence-based guidelines and ongoing research into personalized therapies promise to enhance the care of critically ill patients facing adrenal stress dysregulation.